Nicole LaBrosse

Insider Reports History

Location
San Diego, CA
Signature
/s/ James R. Oehler, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Nicole LaBrosse:

Company Role Class Num Shares Value Price $ Report Date Ownership
HALOZYME THERAPEUTICS, INC. SVP, CHIEF FINANCIAL OFFICER Common Stock 22,079 $1,736,888 $78.67 22 Sep 2025 Direct
HALOZYME THERAPEUTICS, INC. SVP, CHIEF FINANCIAL OFFICER Restricted Stock Units 20,063 $1,158,638 $57.75 23 Feb 2025 Direct
HALOZYME THERAPEUTICS, INC. SVP, CHIEF FINANCIAL OFFICER Performance Stock Unit 6,935 $391,169 $56.40 12 Feb 2025 Direct
HALOZYME THERAPEUTICS, INC. SVP, CHIEF FINANCIAL OFFICER Option to Purchase Common Stock 812 $313,504 $13.87 10 Sep 2025 Direct
HALOZYME THERAPEUTICS, INC. SVP, CHIEF FINANCIAL OFFICER Performance Stock Units 0 $0 $58.29 16 Feb 2025 Direct

Insider Reports Filed by Nicole LaBrosse

Symbol Company Period Transactions Value $ Form Type Role Filing Time
HALO HALOZYME THERAPEUTICS, INC. 22 Sep 2025 2 -$173,584 4 SVP, CHIEF FINANCIAL OFFICER 23 Sep 2025, 16:15
HALO HALOZYME THERAPEUTICS, INC. 10 Sep 2025 6 -$1,364,050 4 SVP, CHIEF FINANCIAL OFFICER 11 Sep 2025, 17:09
HALO HALOZYME THERAPEUTICS, INC. 23 Feb 2025 3 -$207,958 4 SVP, CHIEF FINANCIAL OFFICER 24 Feb 2025, 17:04
HALO HALOZYME THERAPEUTICS, INC. 20 Feb 2025 2 $0 4 SVP, CHIEF FINANCIAL OFFICER 21 Feb 2025, 18:49
HALO HALOZYME THERAPEUTICS, INC. 15 Feb 2025 12 -$918,184 4 SVP, CHIEF FINANCIAL OFFICER 18 Feb 2025, 18:39
HALO HALOZYME THERAPEUTICS, INC. 12 Feb 2025 4 $0 4 SVP, CHIEF FINANCIAL OFFICER 14 Feb 2025, 18:09
HALO HALOZYME THERAPEUTICS, INC. 22 Jul 2024 5 -$157,162 4 SVP, CHIEF FINANCIAL OFFICER 23 Jul 2024, 16:37
HALO HALOZYME THERAPEUTICS, INC. 26 Jun 2024 9 -$882,940 4 SVP, CHIEF FINANCIAL OFFICER 28 Jun 2024, 16:06
HALO HALOZYME THERAPEUTICS, INC. 23 Feb 2024 2 $0 4 SVP, CHIEF FINANCIAL OFFICER 27 Feb 2024, 17:05
HALO HALOZYME THERAPEUTICS, INC. 16 Feb 2024 6 -$202,196 4 SVP, CHIEF FINANCIAL OFFICER 20 Feb 2024, 18:53
HALO HALOZYME THERAPEUTICS, INC. 15 Feb 2024 3 -$24,634 4 SVP, CHIEF FINANCIAL OFFICER 16 Feb 2024, 17:41
HALO HALOZYME THERAPEUTICS, INC. 10 Feb 2024 3 -$52,419 4 SVP, CHIEF FINANCIAL OFFICER 13 Feb 2024, 16:15
HALO HALOZYME THERAPEUTICS, INC. 16 Feb 2023 5 -$124,382 4 SVP, CHIEF FINANCIAL OFFICER 21 Feb 2023, 18:00
HALO HALOZYME THERAPEUTICS, INC. 15 Feb 2023 3 -$30,553 4 SVP, CHIEF FINANCIAL OFFICER 17 Feb 2023, 05:25
HALO HALOZYME THERAPEUTICS, INC. 10 Feb 2023 6 -$101,411 4 SVP, CHIEF FINANCIAL OFFICER 14 Feb 2023, 16:21
HALO HALOZYME THERAPEUTICS, INC. 15 Nov 2022 2 -$269,053 4 SVP, CHIEF FINANCIAL OFFICER 16 Nov 2022, 18:51
HALO HALOZYME THERAPEUTICS, INC. 15 Feb 2022 5 -$14,908 4 SVP, Chief Financial Officer 17 Feb 2022, 17:03
HALO HALOZYME THERAPEUTICS, INC. 10 Feb 2022 9 -$67,483 4 SVP, Chief Financial Officer 14 Feb 2022, 18:28
HALO HALOZYME THERAPEUTICS, INC. 02 Feb 2022 0 $0 3 SVP, Chief Financial Officer 11 Feb 2022, 15:21